This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kobe University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Koichi Kitagawa
Introduction
Koichi Kitagawa is a prominent inventor based in Hyogo, Japan. He has made significant strides in the field of cancer research, particularly in gene therapy. His work focuses on developing novel therapeutic means to combat cancer, showcasing his dedication to advancing medical science.
Latest Patents
Koichi Kitagawa holds a patent for a cancer gene therapy drug. This innovative patent provides a nucleic acid structure that links three essential components: (A) a nucleic acid encoding a protein with a CD44 extracellular function, (B) a nucleic acid encoding a protein with a Notch core region function, and (C) a nucleic acid encoding a protein with an HIF-3α4 function. This unique combination aims to enhance the effectiveness of cancer treatments.
Career Highlights
Kitagawa is affiliated with Kobe University, where he contributes to research and development in the field of gene therapy. His academic background and ongoing research efforts have positioned him as a key figure in the fight against cancer.
Collaborations
Some of his notable coworkers include Toshiro Shirakawa and Naoto Kunimura. Their collaborative efforts in research have furthered the understanding and potential treatment options for cancer.
Conclusion
Koichi Kitagawa's innovative work in cancer gene therapy exemplifies the impact of dedicated research in the medical field. His contributions are paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile